PATENT CLAIM ANALYSIS

Application Number: 15756500
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "078170"]

Abstract:
Disclosed is a hemostatic material, wherein a thrombin receptor activating agent is covalently coupled to a biocompatible matrix.

Claim (Index 2):
The hemostatic material according to  claim 1 , wherein the biocompatible matrix is a hemostatic matrix and is selected from the group consisting of a biomaterial, preferably a protein, a biopolymer or a polysaccharide matrix, especially a collagen, gelatin, fibrin, starch or chitosan matrix; and a synthetic polymer, preferably a polyvinyl alcohol, polyethylene glycol, or poly(N-isopropylacrylamide).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.17647
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14460353', '13173013', '14836014', '13758942', '10251703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7642499832574111
- 35 USC 102 Novelty (BERT): 0.4834275944286166
- Combined Prediction Score: 0.7361677443745317
- Mean Citation Score: 216.677474
- Max Citation Score: 227.17107
- Similarity Product: 181.50990721004248

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test